ATLASCaris Life Sciences (CAI) earnings date: Nov 4, 2026
Caris Life Sciences (CAI) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 4, 2026, after the close. Analysts expect EPS of $0.03.
Source: company filings and exchange data · Updated Nov 2, 2026
Caris Life Sciences reports on Nov 4, 2026. One email the day before, with ATLAS’s read on Caris Life Sciences. You can switch it off at any time.
Alert me before CAI reportsFree to start. Creating an account takes under a minute.
CAI earnings at a glance
| Next report (confirmed) | Wed, Nov 4, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | $0.03 |
| Last report | Aug 5, 2026 · Miss |
| Beat rate (last 7 reports) | 5 of 7 (71%) |
| Average EPS surprise | -750.4% |
| Average move around a report | ±13.4% (last 7) |
| Sector | Healthcare · Biotechnology |
Caris Life Sciences earnings history: last 7 reports
Caris Life Sciences last reported on Aug 5, 2026: EPS of -$0.54 against an estimate of -$0.01 (-5,300.0% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 5, 2026 | -$0.01 | -$0.54 | -5,300.0% | Miss | +24.2% |
| May 7, 2026 | -$0.02 | -$0.00 | +91.0% | Beat | -15.6% |
| Feb 26, 2026 | $0.10 | $0.28 | +180.0% | Beat | +10.0% |
| Nov 5, 2025 | -$0.14 | $0.08 | +157.1% | Beat | -21.1% |
| Oct 24, 2025 | $5.73 | $6.96 | +21.5% | Beat | -4.5% |
| Oct 15, 2025 | $1.34 | $1.37 | +2.2% | Beat | +5.2% |
| Aug 12, 2025 | -$0.22 | -$1.11 | -404.5% | Miss | +13.5% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
ATLAS view on CAI before the report
| Last price | $34.33 (-5.0%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 48% |
| Likely 1-month range (50%) | $30.69 – $37.71 |
| Normal 1-day range (±1σ) | ±3.5% |
| ATLAS fair value | $14.80 ($11.58 – $18.92) · price is 132% above |
These figures come from the same calibrated model and valuation as the Caris Life Sciences stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Get the full ATLAS analysis for CAI
See the fair value, the probability range and the earnings history of Caris Life Sciences on its ATLAS page.
Caris Life Sciences (CAI) stock analysisPlans from €3.99 a month.
Caris Life Sciences earnings: frequently asked questions
When does Caris Life Sciences (CAI) report earnings?
Caris Life Sciences is scheduled to report on Wednesday, November 4, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for CAI?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is $0.03 per share (USD). Estimates can change before the report.
How often does CAI beat earnings estimates?
Of its last 7 reports with a recorded result, Caris Life Sciences beat the EPS estimate 5 times; the average surprise was -750.4%. Past results do not predict the next one.
How much does CAI move around earnings?
Over its last 7 reports the stock moved an average of 13.4% (absolute, from the close before the report day to the close after it), and finished higher 4 of 7 times.
Did Caris Life Sciences beat earnings estimates last quarter?
Caris Life Sciences last reported on Aug 5, 2026: EPS of -$0.54 against an estimate of -$0.01 (-5,300.0% surprise), a miss.
How much does CAI usually move in a day?
On a normal trading day the ATLAS model puts CAI’s one-day range at about ±3.5%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 4, 2026
Educational information, not investment advice. Disclaimer